Objectives This study aimed to compare the efficacy and safety of combination therapy with
high-dose sulbactam or colistin with additional antibacterial agents for treating multidrug …

Objectives To comprehensively compare and rank the efficacy and safety of available
treatment options for patients with MDR and XDR Acinetobacter baumannii (AB) infection …

Background An urgent need exists for antibiotics to treat infections caused by carbapenem-
resistant Acinetobacter baumannii–calcoaceticus complex (ABC). Sulbactam–durlobactam …

Multidrug resistant among Acinetobacter baumannii infection is associated with a high
mortality rate and limits the therapeutic options. The aim of this study was to assess the …

Controversy surrounds combination treatment or monotherapy against multidrug-resistant
(MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) Acinetobacter …

Treatment options for multidrug resistant Acinetobacter baumannii strains (MDR-AB) are
limited. Minocycline has been used alone or in combination in the treatment of infections …

Background Nosocomial infections due to multi-drug resistant Acinetobacter baumannii are
often treated with colistin, but there are few data comparing its safety and efficacy with other …

Acinetobacter baumannii is a leading cause of healthcare-associated infections worldwide.
Because of various intrinsic and acquired mechanisms of resistance, most β-lactam agents …

The purpose of this investigation was to compare the efficacy of colistin-based therapies in
extremely drug-resistant Acinetobacter spp. bloodstream infections (XDR-ABSI). A …

Background. Extensively drug-resistant (XDR) Acinetobacter baumannii may cause serious
infections in critically ill patients. Colistin often remains the only therapeutic option. Addition …